Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Fusion Pharm Inc FSPM

FusionPharm, Inc. operates in the organic/locally produced food industry. The Company develops and integrates its PharmPod line of cultivation containers. The Company is a creator and manufacturer of these cultivation container systems. The Company offers PharmPlex farming solutions. The Company's PharmPods are used to cultivate a range of plants for businesses, universities and individuals... see more

Recent & Breaking News (GREY:FSPM)

FusionPharm Intends to Liquidate and Dissolve Company

Marketwired May 3, 2017

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In FusionPharm, Inc. To Contact The Firm

Business Wire March 27, 2017

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In FusionPharm, Inc. (FSPM) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

GlobeNewswire March 14, 2017

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In FusionPharm, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire March 1, 2017

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In FusionPharm, Inc. (FSPM) To Contact Brower Piven Before The Lead Plaintiff Deadline

GlobeNewswire February 22, 2017

Lifshitz & Miller LLP Files Class Action Lawsuit against FusionPharm, Inc.

PR Newswire February 17, 2017

Lifshitz & Miller Law Firm Announces Investigation of Electronics for Imaging, Inc., Ferrellgas Partners LP, Fusion Pharm, Inc., Humana Inc., KemPharm, Inc., National Beverage Corp., Puma Biotechnology, Inc., and TG Therapeutics, Inc.

PR Newswire October 31, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Fusion Pharm, Inc. (FSPM)

PR Newswire October 6, 2016

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Fusion Pharm, Inc.

Business Wire October 3, 2016

Supreme Gears Up MMPR with Pre-License Facility Improvements

Accesswire December 22, 2014

CannabisFN Weekly: Stocks Tread Water amid Regulatory Gains

Accesswire June 17, 2014

CannabisFN Weekly: Stocks Mixed Despite Favorable Legalization Trends

Accesswire May 20, 2014

U.S. regulator cracks down on OTC marijuana stocks (FSPM) (PHOT) (PTOG)

Stockhouse Editorial May 16, 2014

MediJane Holdings Completes Distribution Agreement With GoKush.com

Accesswire May 16, 2014

FusionPharm Announces First Quarter Results and Operational Highlights

GlobeNewswire May 16, 2014

Vapor Corp. Plans To Release Q1 Financial Results On May 15th, 2014

Accesswire May 9, 2014

Freedom Energy Holdings' CEO Exchanges 1 Billion Common Shares for 10,000 Preferred

Accesswire April 24, 2014

CannaBusiness Group New Subsidiary Hires Chief Technology Officer

Accesswire April 14, 2014

Growlife Inc.'s Annual Report Shows a Net Loss of $21 million for 2013

Accesswire April 2, 2014

FusionPharm ships 2nd Canadian order

GlobeNewswire March 27, 2014